The report is based on limited data according to federal health regulators.
booster of johnson and johnsonFederal health regulators said Wednesday that the COVID-19 vaccine showed signs of significantly strengthening the immune defenses of study subjects.
However, regulators cautioned that the data was limited and they had to rely on J&J’s own analysis for some of the study findings rather than conducting their own.
FDA says benefits of modern vaccine outweigh risks after limited use in Nordic countries
Food and Drug Administration staff gave their evaluation of J&J booster data as part of the agency’s review of the company’s request for authorization of a second dose.
After authorizing boosters for seniors and certain high-risk people who have received the COVID-19 vaccine pfizer Inc. and BioNTech SE, the FDA is now considering whether to approve additional doses of shots from J&J and Moderna. It is also being weighed whether dosages can be mixed between different vaccines.
FDA released its staff evaluation, along with other materials, regarding J&J’s booster request.